David Brailer’s June 11, 2026, commentary in Health Affairs Forefront describes how US health care payers and providers use ...

The premise of Medicaid as a policy laboratory rests on generating knowledge through rigorous evaluation. Yet, too often, ...

Under the FDA’s regulatory authority, drug companies, prescribers, and patients operate under one national standard for drug ...

Three federal actions are putting intense pressure on the clinical dietetics workforce, just when it’s needed the most.

Recent evidence on cash transfers and child health is mixed, suggesting that cash transfers may be a necessary but ...

The Clover decision and resulting instability offer an opportunity to step back and assess how the Medicare Advantage quality ...

So far, efforts to reform society’s relationship with screen time have focused on children. Now, as it becomes increasingly ...

If the relevant question is how to obtain the greatest health value for the money spent, a cost-effectiveness analysis or ...

If all states adopt the Immigrant Children’s Health Improvement Act in the next few months, more lawfully residing immigrant children and pregnant women, such as refugees, could retain their ...

We’ve built global highways for approved medicines and left clinical trial access on something closer to dirt roads.

The 340B fights of 2026 are being waged as disputes over fairness and intent. Underneath, they are disputes over data.

Without data that support plan level evaluation, accountability for Medicare Advantage dental benefits remains aspirational rather than operational.